The immunisation campaign against these 2 severe illnesses will now start after Corona



 New Delhi: In India, a vaccination campaign against the coronavirus pandemic is now underway, and 197 crore doses of the vaccine have been given. After that, a vaccine campaign against typhoid and cervical cancer may shortly begin. After reviewing the information, the Government Advisory Group (NTAGI) advised vaccination against typhoid and cervical cancer.

The National Technical Advisory Group on Immunization against Cervical Cancer and Typhoid (NTAGI), according to sources, held a separate HPV working group meeting on June 8 to review the results of clinical trials and the efficacy of the vaccine for inclusion in the national immunisation programme. Official sources state that on June 15, the Central Drugs Standard Control Organization’s (CDSCO) topic expert group recommended granting the vaccine’s marketing authorization. However, the approval of India’s drug controller general (DCGI) is still pending.

sources reported In order to ensure that the vaccine is available in India as soon as phase 2/3 clinical trials are finished, Prakash Kumar Singh, director of government and regulatory affairs at the Serum Institute of India (SII), has submitted an application to the Drugs Controller General of India (DCGI) of India and requested marketing permission for the vaccine. This application was made with the assistance of the Department of Biotechnology. The vaccine, CERVAVAC, has demonstrated a significant antibody response that is around 1,000 times greater depending on all the targeted HPV types, all doses, and all age groups, according to the application submitted by Prakash Kumar Singh.